Free Trial

Nemaura Medical (NMRD) Competitors

Nemaura Medical logo

NMRD vs. AHPI, MOTS, UTRS, VIVE, DRTSW, ANZUW, ATAKW, BBLGW, BRSHW, and CTCXW

Should you be buying Nemaura Medical stock or one of its competitors? The main competitors of Nemaura Medical include Allied Healthcare Products (AHPI), Motus GI (MOTS), Minerva Surgical (UTRS), Viveve Medical (VIVE), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), and Carmell (CTCXW). These companies are all part of the "medical equipment" industry.

Nemaura Medical vs. Its Competitors

Nemaura Medical (NASDAQ:NMRD) and Allied Healthcare Products (NASDAQ:AHPI) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk, media sentiment and valuation.

Company Net Margins Return on Equity Return on Assets
Nemaura MedicalN/A N/A N/A
Allied Healthcare Products N/A N/A N/A

Allied Healthcare Products has higher revenue and earnings than Nemaura Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nemaura Medical$3.02K0.00-$14.14M-$0.39N/A
Allied Healthcare Products$27.05M0.00-$5.36M-$1.34N/A

Nemaura Medical has a beta of 0.5, suggesting that its share price is 50% less volatile than the S&P 500. Comparatively, Allied Healthcare Products has a beta of -2.39, suggesting that its share price is 339% less volatile than the S&P 500.

In the previous week, Nemaura Medical's average media sentiment score of 0.00 equaled Allied Healthcare Products'average media sentiment score.

Company Overall Sentiment
Nemaura Medical Neutral
Allied Healthcare Products Neutral

4.4% of Nemaura Medical shares are held by institutional investors. Comparatively, 4.2% of Allied Healthcare Products shares are held by institutional investors. 40.4% of Nemaura Medical shares are held by insiders. Comparatively, 5.1% of Allied Healthcare Products shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Nemaura Medical beats Allied Healthcare Products on 5 of the 7 factors compared between the two stocks.

Get Nemaura Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for NMRD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NMRD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

NMRD vs. The Competition

MetricNemaura MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$4K$256.87M$5.53B$9.02B
Dividend YieldN/AN/A5.22%3.99%
P/E Ratio0.005.9227.8120.25
Price / SalesN/A73.84429.10119.26
Price / CashN/A196.1226.2128.59
Price / BookN/A6.338.025.65
Net Income-$14.14M-$27.18M$3.18B$249.15M

Nemaura Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NMRD
Nemaura Medical
1.1751 of 5 stars
N/AN/AN/A$4K$3.02K0.0040
AHPI
Allied Healthcare Products
N/AN/AN/AN/A$16K$27.05M0.00150Gap Up
MOTS
Motus GI
0.0757 of 5 stars
$0.00
flat
N/AN/A$2K$319K0.0030
UTRS
Minerva Surgical
N/AN/AN/AN/A$1K$51.69M0.00160
VIVE
Viveve Medical
N/A$0.00
flat
N/AN/A$1K$6.83M0.0070
DRTSW
Alpha Tau Medical
N/A$0.24
-1.7%
N/AN/A$0.00N/A0.0080Positive News
ANZUW
Anzu Special Acquisition Corp I
N/A$0.04
-31.2%
N/AN/A$0.00N/A0.002
ATAKW
Aurora Technology Acquisition
N/A$0.02
-2.2%
N/A-64.1%$0.00N/A0.00N/AGap Up
BBLGW
Bone Biologics
N/A$15.00
flat
N/A-65.5%$0.00N/A0.002Gap Up
BRSHW
Bruush Oral Care
N/AN/AN/AN/A$0.00$2.92M0.0011
CTCXW
Carmell
N/A$0.03
+6.8%
N/AN/A$0.00$32.84K0.0014Gap Up

Related Companies and Tools


This page (NASDAQ:NMRD) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners